Intrance Medical Systems is a biopharmaceutical company.
Intrance Medical Systems has raised $17.0M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Intrance Medical Systems's investors include Rutger Arnhult, Erik Selin, Ed Schutter.
Intrance Medical Systems is headquartered in New York, United States.
Intrance Medical Systems is a biopharmaceutical company.
Intrance Medical Systems is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intrance Medical Systems — Funding & Investors." VCBacked, January 4, 2022, https://www.vcbacked.co/company/intrance-medical-systems. Accessed August 24, 2026.
VCBacked. (2022). Intrance Medical Systems — Funding & Investors. Retrieved August 24, 2026, from https://www.vcbacked.co/company/intrance-medical-systems
{{cite web |title=Intrance Medical Systems — Funding & Investors |url=https://www.vcbacked.co/company/intrance-medical-systems |website=VCBacked |access-date=August 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated